NCT00000626 2021-10-27Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's DiseaseNational Institute of Allergy and Infectious Diseases (NIAID)Phase 2 Completed27 enrolled